EPELSIBAN
UNII T2EZ19HX73

Substance Identification & Data

This profile provides standardized clinical and technical data for Epelsiban, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T2EZ19HX73.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 872599-83-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T2EZ19HX73

CAS Registry Number

872599-83-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EPELSIBAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C30H38N4O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UWHCWRQFNKUYCG-QUZACWSFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C99151

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11634973

Unique identification number in the NCBI database of chemical substances.

INN ID

9453

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-152

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(cccc1)CC([C@H]3NC(=O)[C@@]([C@@H](C)CC)(N([C@H](c4ccc(C)nc4C)C(N5CCOCC5)=O)C3=O)[H])C2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Epelsiban. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EPELSIBAN

Common Names & Synonyms

2,5-PIPERAZINEDIONE, 3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2,6-DIMETHYL-3-PYRIDINYL)- 2-(4-MORPHOLINYL)-2-OXOETHYL)-6-((1S)-1-METHYLPROPYL)-, (3R,6R)-

3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2,6-DIMETHYLPYRIDIN-3-YL)-2-(MORPHOLIN-4-YL)-2-OXOETHYL)-6-((1S)-1-METHYLPROPYL)PIPERAZINE-2,5-DIONE

EPELSIBAN [INN]

EPELSIBAN [USAN]

EPELSIBAN [WHO-DD]

Systematic Nomenclature

(3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2,6-DIMETHYLPYRIDIN-3-YL)-2-(MORPHOLIN-4-YL)-2-OXOETHYL)-6-((2S)-BUTAN-2-YL)PIPERAZINE-2,5-DIONE

SYS

2,5-PIPERAZINEDIONE, 3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2,6-DIMETHYL-3-PYRIDINYL)-2-(4-MORPHOLINYL)-2-OXOETHYL)-6-((1S)-1-METHYLPROPYL)-, (3R,6R)-

SYS

MORPHOLINE, 4-((2R)-((3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-6-((1S)-1-METHYLPROPYL)-2,5-DIOXO-1-PIPERAZINYL)(2,6-DIMETHYL-3-PYRIDINYL)ACETYL)-

SYS